
High-end Medical Device R&D and Manufacturer
Source of the article:MedRobot;Editor: Jacky
Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.



NO.1 Approved by NMPA! Jingfeng®Bronchoscopy Robot CP1000
On January 27, 2025, the natural orifice surgical robot independently developed by Frontier Medical——MicroEdge®Bronchoscopy Robot CP1000(hereinafter referred to as Jingfeng)®CP1000), officially received the marketing approval from the National Medical Products Administration (NMPA) (Registration Certificate No.: Z20253010298).
This product is the third approved robotic product by MicroPort in the field of minimally invasive surgery, making itThe First in China, the Second InternationallyA company that has successfully covered the three major surgical robot fields of multi-port, single-port, and natural orifice transluminal endoscopic surgery (NOTES) and gone public., marking a significant breakthrough in its technology research and development and market layout.

From a technical perspective, MicroPort®CP1000 is a pioneering work in the field of natural orifice surgical robot technology.With its flexible endoscope technology, Jingfeng®CP1000 can precisely operate through the respiratory tract., avoiding trauma and incisions in traditional surgery, significantly improving the precision of the operation, and shortening the patient's postoperative recovery time while reducing the risk of infection. Particularly in lung biopsy and adjuvant treatment, MicroPort®CP1000 provides surgeons with a more reliable surgical tool, suitable for complex MicroPort operations.
Related Reading:Heavyweight! MicroPort® Bronchoscope Robot CP1000 Receives NMPA Marketing Approval!
NO.2 Yuanhua Orthopedic Surgery Robot Collaborates with 3D Printing to Drive Medical Technology Innovation
January 23, 2025,Yuanhua Intelligent Technology (Hong Kong) Co., Ltd.(hereinafter referred to as "Yuanhua Intelligence (Hong Kong)") andConen 3D Technology (Medical) Co., Ltd.(hereinafter referred to as "KORNEL") signed a strategic cooperation agreement at Hong Kong Science Park,Marks the beginning of in-depth cooperation between the two parties in the fields of orthopedic surgical robots and personalized prosthesis 3D printing technology.,jointly promote the innovative development of medical technology, and enhance the intelligence and personalization levels of medical services.

At the signing ceremony, Meng Li Aili, Chairman of Yuanhua Intelligence (Hong Kong), and Qiu Rongfeng, Chairman of Keneng 3D Technology (Medical), both expressed that this cooperation is a perfect integration of the technical advantages of both parties. The two parties will jointly explore new fields of medical technology, inject strong momentum into the development of Hong Kong's medical technology, bring more high-quality and advanced medical services to patients, and contribute "Hong Kong wisdom" and "Hong Kong solutions" to the progress of global medical technology.
NO.3 Approved by NMPA! MicroPort Single-Port Laparoscopic Surgical Robot
On February 11, 2025, Shanghai MicroPort Medical Robot (Group) Co., Ltd. independently developedTumai®Single-Port Endoscopic Surgical Robot(abbreviation: Tu Mai)®Single-port) has officially received approval from the National Medical Products Administration for market launch (Registration Certificate No.: GuoXieZhuZhun 20253010347), applicable to clinical surgeries across multiple departments including urology, general surgery, and gynecology.

Tumai®Single-port adopts a highly integrated single-port design,Composed of a doctor's console, patient operating platform, image processing system, high-definition 3D electronic laparoscope, surgical instruments, and accessories., with the advantages of minimally invasive, smooth, intelligent, and comfortable. Its performance parameters in terms of master hand operating force, master-slave mapping frequency, image delay, and endoscope lifespan have all reached internationally leading levels, providing surgeons with excellent hand-eye coordination consistency, flexibility and precision surpassing human hands, superb 3D stereoscopic visual effects, and a "human-machine integration" control experience, achieving ultimate minimal trauma.
NO.4 Approved by NMPA! Tasly Sainacure Non-Invasive Ultrasound Surgical Robot
On January 26, 2025, the National Medical Products Administration approved Tianjin Tasly Sainekang."Transrectal High-Intensity Focused Ultrasound Therapy Device"Product Registration Application (Registration Certificate No.: China Medical Device Registration 20253010295).
HIFU (High-Intensity Focused Ultrasound) is a non-invasive treatment method that utilizesFocused UltrasoundGenerate high temperatures in the body, causing protein denaturation and necrosis in tumor tissues, thereby achieving the therapeutic goal.However, its application advantages are not limited to thermal effects. It also has unique non-thermal effects, including mechanical and cavitation effects. The mechanical effect directly inhibits tumor growth by disrupting the structure of tumor cells, while the cavitation effect enhances the destructive impact by generating tiny bubbles within the tumor tissue. This synergistic effect of multiple mechanisms further provides a theoretical basis for the high efficiency of HIFU technology in clinical treatment.
In 2022, Sonablate and Tasly Pharmaceutical Group joined forces to establish Tasly SonaMed, focusing on introducing AI-HIFU technology into the Chinese market. As a leading pharmaceutical enterprise in China, Tasly’s collaboration with Sonablate not only brings in the technology but also integrates AI-HIFU into the Chinese healthcare system through localized production and R&D.
Related Reading:The Path of Transformation in Tumor Treatment: Unveiling the Technology Behind Non-Invasive Ultrasound Surgical Robots
NO.5 Approved by NMPA! Tianzhihang Orthopedic Surgery Robot
On February 13, 2025, Tianzhihang announced that its orthopedic surgery navigation and positioning system had obtained the medical device registration certificate issued by the National Medical Products Administration (Registration Certificate No.: G20253010349).

This product will be used for the navigation and positioning of surgical instruments or implants in open or percutaneous surgeries within spinal surgery and trauma orthopedics; in adult total knee arthroplasty and total hip arthroplasty, it will be used in conjunction with verified prostheses and surgical tools for the navigation and positioning of prostheses and surgical tools.
Orthopedic surgical robots are mainly applied inJoint replacement surgery, spinal surgery, and orthopedic trauma surgeryThe indications for this certified product cover full-segment spinal surgeries, including the cervical, thoracic, lumbar, and sacral vertebrae, as well as trauma surgeries in areas such as the pelvis, acetabulum, and limbs, in addition to total knee arthroplasty and total hip arthroplasty. The approval of this product will help diversify the company’s product portfolio and continuously meet a wide range of clinical needs.
NO.6 Approved by NMPA! Ruihe Medical Total Knee Arthroplasty Surgical Robot
January 24, 2025Day,National Medical Products Administration approves Hebei Ruihe Medical Device Co., Ltd."Total Knee Arthroplasty Surgical Navigation System"Product Registration Application (Registration Certificate No.: G20253010228).
RealHealth's joint replacement surgery robot utilizes an intelligent optical tracking system,The robotic arm can achieve precise control of osteotomy positioning and provide excellent prediction of the prosthesis placement pre-operatively, intra-operatively, and post-operatively., combined with soft tissue balance, further enhances the stability of prosthesis installation, thereby improving patient satisfaction with the surgery and making the entire procedure more digital and intelligent. In addition, it allows for a full understanding of the joint motion status, real-time detection of joint kinematic characteristics, and simultaneously provides feedback on stability results.
NO.7 Approved by NMPA! Zhenzheng Orthopedic Surgery Robot
February 11, 2025, byOrthopedic Surgery Navigation and Positioning System (also known as Zohoo 500 Surgical Robot) developed by Zhuzheng Robotics, officially received the market approval from the National Medical Products Administration (Registration Certificate No.:China Medical Device Registration Certificate 20253010231).

Zohar 500 Surgical RobotCapable of achieving intuitive and precise positioning, whether it’s 3D registration or 2D registration, it performs with ease. During the surgical process, the Zohance 500 can intelligently plan probe paths, accurately navigate surgical instruments and tools, ensuring every step of the operation is under control. Its wide range of applications covers multiple areas including spinal surgery, orthopedic trauma, hand and foot surgery, as well as sports medicine, demonstrating strong adaptability and practicality.
NO.8 Approved by NMPA! The Lancet Hip and Knee Integrated Joint Replacement Robot
February 14, 2025Hangzhou LANCET Robotic New Product ––Hip-Knee Integrated Joint Replacement RobotApproved for marketing by the National Medical Products Administration.

Product Features:
One Machine, Two Functions, Leading the Trend: Breaking Traditional Boundaries, One Device for Both Hip and Knee Joint Replacements, Efficient and Convenient.
Intelligent Planning, Precise Customization: Based on the patient's 3D imaging data, intelligent algorithms accurately outline the surgical blueprint with millimeter-level precision, providing a tailored solution.
Real-time Navigation, Safe Escort: Full-process real-time tracking during surgery, precise navigation, equipping doctors with "X-ray vision," significantly increasing surgical safety.
Breaking from Tradition, Direct Osteotomy: The robot performs bone cutting directly without the assistance of traditional osteotomy guides, reducing human error and enabling intelligent control of osteotomy boundaries.
NO.9 Approved by NMPA! ZhiDao Surgical Hair Transplant Robot
February 13, 2025Day, Shanghai Shuzhi Dao Robotics Co., Ltd. (hereinafter referred to as "Shuzhi Dao") independently developedHair Transplant RobotOfficially received the marketing approval from the National Medical Products Administration (NMPA) (Registration Certificate No.: Z20253010352).

The ARTAS iX Robotic Hair Restoration System, through its self-developed intelligent algorithms, vision system, and robotic arm system, achieves full autonomy from the core components of the robotic arm to the control software. Its modular design supports rapid iteration and upgrades, precisely meeting clinical needs.
Chinese Surgical Robots (Listed Collection)
▌Cavity Mirror Surgical Robot
▌Orthopedic Surgery Robot
▌Vascular Interventional Surgical Robot
▌Puncture Surgery Robot
▌Microwave Ablation Surgical Robot
ZhenYiDa®Navigation and Positioning Microwave Ablation System
Comprehensive▌MicroPort Robot | TaoDao Medical
Endoscope▌MicroPort Medical | Sizherui Intelligent Medical | SureRobot
Orthopedics▌Rosenthal | Yuanhua Intelligence | Changmu Valley | Xin Jun Te
Vascular Intervention▌Aibohc
Puncture Robot▌True Health
Weekly Report on Bid Wins | Approved Weekly Report | Industry Weekly Report
Progress of Chinese Surgical Robot Companies | Progress of Overseas Surgical Robot Companies
